- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
-
- Saito, Akatsuki
- Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki; Center for Animal Disease Control, University of Miyazaki; Graduate School of Medicine and Veterinary Medicine, University of Miyazaki
-
- Irie, Takashi
- Institute of Biomedical and Health Sciences, Hiroshima University
-
- Suzuki, Rigel
- Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University
-
- Maemura, Tadashi
- Division of Virology, Institute of Medical Science, University of Tokyo; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison
-
- Nasser, Hesham
- Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University; Department of Clinical Pathology, Faculty of Medicine, Suez Canal University
-
- Uriu, Keiya
- Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo
-
- Kosugi, Yusuke
- Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo
-
- Shirakawa, Kotaro
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
- Sadamasu, Kenji
- Tokyo Metropolitan Institute of Public Health
-
- Kimura, Izumi
- Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo
-
- Ito, Jumpei
- Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo
-
- Wu, Jiaqi
- Department of Molecular Life Science, Tokai University School of Medicine; CREST, Japan Science and Technology Agency
-
- Iwatsuki-Horimoto, Kiyoko
- Division of Virology, Institute of Medical Science, University of Tokyo
-
- Ito, Mutsumi
- Division of Virology, Institute of Medical Science, University of Tokyo
-
- Yamayoshi, Seiya
- Division of Virology, Institute of Medical Science, University of Tokyo;The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute
-
- Loeber, Samantha
- Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin
-
- Tsuda, Masumi
- Department of Cancer Pathology, Faculty of Medicine, Hokkaido University; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University
-
- Wang, Lei
- Department of Cancer Pathology, Faculty of Medicine, Hokkaido University; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University
-
- Ozono, Seiya
- Department of Pathology, National Institute of Infectious Diseases
-
- Butlertanaka, Erika P.
- Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki
-
- Tanaka, Yuri L.
- Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki
-
- Shimizu, Ryo
- Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University; Graduate School of Medical Sciences, Kumamoto University
-
- Shimizu, Kenta
- Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University
-
- Yoshimatsu, Kumiko
- Institute for Genetic Medicine, Hokkaido University
-
- Kawabata, Ryoko
- Institute of Biomedical and Health Sciences, Hiroshima University
-
- Sakaguchi, Takemasa
- Institute of Biomedical and Health Sciences, Hiroshima University
-
- Tokunaga, Kenzo
- Department of Pathology, National Institute of Infectious Diseases
-
- Yoshida, Isao
- Tokyo Metropolitan Institute of Public Health
-
- Asakura, Hiroyuki
- Tokyo Metropolitan Institute of Public Health
-
- Nagashima, Mami
- Tokyo Metropolitan Institute of Public Health
-
- Kazuma, Yasuhiro
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
- Nomura, Ryosuke
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
- Horisawa, Yoshihito
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
- Yoshimura, Kazuhisa
- Tokyo Metropolitan Institute of Public Health
-
- Takaori-Kondo, Akifumi
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
- Imai, Masaki
- Division of Virology, Institute of Medical Science, University of Tokyo; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute
-
- Chiba, Mika
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Furihata, Hirotake
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Hasebe, Haruyo
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Kitazato, Kazuko
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Kubo, Haruko
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Misawa, Naoko
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Morizako, Nanami
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Noda, Kohei
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Oide, Akiko
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Suganami, Mai
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Takahashi, Miyoko
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Tsushima, Kana
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Yokoyama, Miyabishara
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Yuan, Yue
- The Genotype to Phenotype Japan (G2P-Japan) Consortium
-
- Tanaka, Shinya
- Department of Cancer Pathology, Faculty of Medicine, Hokkaido University; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University
-
- Nakagawa, So
- Department of Molecular Life Science, Tokai University School of Medicine; CREST, Japan Science and Technology Agency
-
- Ikeda, Terumasa
- Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University
-
- Fukuhara, Takasuke
- Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University
-
- Kawaoka, Yoshihiro
- Division of Virology, Institute of Medical Science, University of Tokyo; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute
-
- Sato, Kei
- Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo; CREST, Japan Science and Technology Agency
Search this article
Description
During the current SARS-CoV-2 pandemic, a variety of mutations have accumulated in the viral genome, and currently, four variants of concern (VOCs) are considered potentially hazardous to human society1. The recently emerged B.1.617.2/Delta VOC is closely associated with the COVID-19 surge that occurred in India in the spring of 20212. However, its virological properties remain unclear. Here, we show that the B.1.617.2/Delta variant is highly fusogenic and notably more pathogenic than prototypic SARS-CoV-2 in infected hamsters. The P681R mutation in the spike protein, which is highly conserved in this lineage, facilitates spike protein cleavage and enhances viral fusogenicity. Moreover, we demonstrate that the P681R-bearing virus exhibits higher pathogenicity than its parental virus. Our data suggest that the P681R mutation is a hallmark of the virological phenotype of the B.1.617.2/Delta variant and is associated with enhanced pathogenicity.
Journal
-
- Nature
-
Nature 602 (7896), 300-306, 2022-02-10
Springer Nature
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1050574334845633408
-
- ISSN
- 14764687
- 00280836
-
- HANDLE
- 2433/275414
- 2115/84468
-
- PubMed
- 34823256
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- IRDB
- Crossref
- KAKEN
- OpenAIRE